文献速递肾小球疾病遗传性与小管间质肾病

Alport综合征与肾囊肿表型无显著关联

Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

该多中心回顾性研究纳入257例经基因确诊的COL4A3/COL4A4/COL4A5变异Alport综合征患者,其中38例(14.8%)存在多发性肾囊肿(MKC)。与990例外显子测序阴性对照比较,单因素及多因素分析均未发现Alport综合征与MKC显著关联,提示MKC可能不应纳入Alport综合征谱系。

要点

  • 257例Alport综合征患者中MKC患病率为14.8%,未发现遗传性囊性肾病 panel 变异。
  • MKC与男性、心血管危险因素及功能丧失变异相关,肾功能衰竭发生晚约6年。
  • 与ES-UKD对照比较未显示Alport综合征与MKC显著关联,不支持将MKC归入Alport谱系。

核心结论

  • 在257例Alport综合征队列中MKC患病率为14.8%,但综合大样本ES-UKD对照分析未发现MKC与Alport综合征显著关联,质疑将MKC纳入Alport综合征谱系。

研究设计与样本

  • 多中心回顾性研究,纳入2011年1月至2023年1月法国四所大学医院经基因分型携带致病性COL4A3、COL4A4或COL4A5变异(ACMG-AMP 4或5级)的患者257例。
  • MKC定义为每肾囊肿≥3个;对照组为原因未明肾病且外显子测序阴性(ES-UKD)患者990例。

主要发现

  • 257例Alport综合征患者中38例(14.8%)存在MKC,且未发现遗传性囊性肾病 panel 变异。
  • MKC与男性性别显著相关(P=0.004),与心血管危险因素及功能丧失变异相关(P=0.012)。
  • MKC患者肾功能衰竭发生显著晚约6年(P=0.035)。
  • 与ES-UKD对照组比较,单因素和多因素分析均未显示Alport综合征与MKC显著关联。
  • 多因素分析显示患者年龄和男性性别(P<0.001)与MKC相关。

临床怎么用

  • 对Alport综合征患者发现多发性肾囊肿时,应考虑其临床和病理特征类似肾血管硬化,不宜直接归因于Alport综合征本身。

局限性

  • 回顾性研究设计;MKC定义基于每肾囊肿≥3个;对照为外显子测序阴性的原因未明肾病患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alport syndromes (AS) are the second leading genetic cause of kidney failure. Whether the multiple kidney cysts (MKC) phenotype belongs to the AS spectrum remains debated. METHODS: This multicenter retrospective study focused on patients genotyped with pathogenic COL4A3, COL4A4, or COL4A5 variants (classified as ACMG-AMP 4 or 5) between January 2011 and January 2023 across four French university hospitals. The study aimed to compare characteristics between two groups based on the presence or absence of MKC, defined by three or more cysts per kidney. The MKC group was compared to a control group with negative exome sequencing results for undetermined kidney disease (ES-UKD) to assess the association between MKC and AS. RESULTS: Among the 257 AS patients included, 38 (14.8%) presented MKC without variation from hereditary cystic kidney panel. MKC showed a significant association with male gender (P = 0.004), cardiovascular risk factors, and loss of function variants (P = 0.012). Kidney failure onset appeared significantly later, by 6 years, in MKC patients (P = 0.035). Comparison with the ES-UKD (n = 990) control group showed no significant association between AS and MKC by univariate and multivariate analysis. Multivariate analysis identified patient age and male gender (P < 0.001) as factors linked to MKC. CONCLUSIONS: A 14.8% prevalence of MKC was found in our cohort of 257 patients with AS. MKC-AS patients exhibited clinical and histological characteristics akin to nephroangiosclerosis. Our comprehensive analysis, incorporating a sizable ES-UKD cohort, revealed no significant association between MKC and AS, thus questioning the inclusion of MKC within the spectrum of AS.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Pagniez MS, Lombardi Y, Fages V, et al. Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype. Nephrol Dial Transplant. 2025. PMID: 39694697. doi:10.1093/ndt/gfae290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。